Actively Recruiting
Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
Led by Clover Biopharmaceuticals USA, LLC · Updated on 2025-05-14
160
Participants Needed
5
Research Sites
62 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
CLO-SCB-1019-002 is the first study of SCB-1019T vaccine for revaccination in older adults who were previously vaccinated with AREXVY. The safety, tolerability and immunogenicity of SCB-1019T are assessed.
CONDITIONS
Official Title
Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female participants 60-85 years of age at the screening visit who received AREXVY before
- Willing and able to comply with study requirements including visits, vaccination, lab tests, and procedures
- Willing and able to give informed consent prior to screening
- Healthy participants or those with stable medical conditions not requiring recent therapy changes or hospitalization
You will not qualify if you...
- Acute disease or fever (≥38°C) at time of vaccination; minor illness without fever may be allowed
- Recurrent or uncontrolled neurological disorders or seizures
- Serious or unstable chronic illnesses
- History of dementia or medical conditions impairing cognition moderately or severely
- History of severe adverse reaction to vaccines or severe allergy to vaccine components
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
AMR Phoenix
Phoenix, Arizona, United States, 85282
Actively Recruiting
2
AMR Fort Myers
Fort Myers, Florida, United States, 33912
Actively Recruiting
3
AMR Lexington
Lexington, Kentucky, United States, 40509
Actively Recruiting
4
AMR Kansas City
Kansas City, Missouri, United States, 64114
Actively Recruiting
5
Knoxville
Knoxville, Tennessee, United States, 37909
Actively Recruiting
Research Team
X
Xuesong Pei, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here